Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
Go back to Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development| StemCells, Inc. (NASDAQ: TEM) | Delayed: 49.01 -1.83 (3.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.84 | 52 Week High | $0.45 | |||
| Open | $49.75 | 52 Week Low | $0.37 | |||
| Day High | $51.27 | P/E | N/A | |||
| Day Low | $47.64 | EPS | $-0.31 | |||
| Volume | 2,837,485 | |||||
